Search

Leon Roslyn Ellenbogen

from Seattle, WA
Age ~97
Get Report
Also known as:
Leon Living Ellenbogen, Leon R Ellenbogen, Roslyn Ellenbogen, Leo Ellenbogen, Leon N
Related to:
Steven M Steinberg, 75Paul Ellenbogen, 34Zachary W Ellenbogen, 31Sandra E Ellenbogen, 68Rachel L Ellenbogen, 36Roslyn B Ellenbogen, 95Paulm EllenbogenRichard G Ellenbogen, 66Leen EllenbogenCheryl S Ellenbogen, 64Richard G EllenbogenPaul Ellenbogen, 34
Connected to:
Cindy L Ellenbolt, 69Blake A Ellenburg, 33Crystal L Ellenburg, 39Fred R Ellenburg, 86Justin L Ellenburg, 72Katie Ellenburg, 42Kayla J Ellenburg, 35Lauren C Ellenburg, 36Muriel A Ellenburg, 56Rosa A Ellenburg, 86

Leon Ellenbogen Phones & Addresses

  • Seattle, WA
  • 16 Morris Dr, New City, NY 10956 (845) 634-5731
  • 14204 Campanelli Dr, Delray Beach, FL 33484 (561) 498-4512
  • Bardonia, NY
  • Palm Beach, FL

Business Records

Name / Title
Company / Classification
Phones & Addresses
Leon Ellenbogen
LEON ELLENBOGEN NUTRITION CONSULTANTS, INC
16 Morris Dr, New City, NY 10956

Publications

Us Patents

Nutritional Supplement To Treat Macular Degeneration

View page
US Patent:
6660297, Dec 9, 2003
Filed:
Mar 23, 2001
Appl. No.:
09/816284
Inventors:
Stephen Paul Bartels - Wyckoff NJ
Cara Larraine Baustian - Palisades NY
George Edwin Bunce - Blacksburg VA
Leon Ellenbogen - New City NY
Jin Kinoshita - El Macero CA
David A. Souerwine - Pittsford NY
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
A61K 920
US Classification:
424464, 424451, 424489, 424400, 424427
Abstract:
A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.

Nutritional Supplement To Treat Macular Degeneration

View page
US Patent:
8603522, Dec 10, 2013
Filed:
Jan 13, 2005
Appl. No.:
11/034656
Inventors:
Stephen Paul Bartels - Pittsford NY, US
Cara Larraine Baustian - Palisades NY, US
George Edwin Bunce - Blacksburg VA, US
Leon Ellenbogen - New City NY, US
Jin Kinoshita - El Macero CA, US
David A. Souerwine - Pittsford NY, US
Assignee:
Bausch & Lomb Incorporated - Rochester NY
International Classification:
A61K 9/20
US Classification:
424464, 424400, 424427, 424451, 424489
Abstract:
A daily nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The ingredients of the daily nutritional or dietary supplement composition include vitamin C, vitamin E, lutein, zinc and copper. The ingredients are preferably provided in a tablet form suitable for oral ingestion.

Nutritional Supplement To Treat Macular Degeneration

View page
US Patent:
20040052863, Mar 18, 2004
Filed:
Aug 15, 2003
Appl. No.:
10/641668
Inventors:
Stephen Bartels - Pittsford NY, US
Cara Baustian - Palisades NY, US
George Bunce - Blacksburg VA, US
Leon Ellenbogen - New City NY, US
Frederick Ferris - Columbia MD, US
Jin Kinoshita - El Macero CA, US
James Smith - Glenn Dale MD, US
David Souerwine - Pittsford NY, US
International Classification:
A61K031/355
A61K033/34
A61K033/32
A61K031/375
A61K031/015
US Classification:
424/638000, 424/643000, 514/458000, 514/474000, 514/763000
Abstract:
A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.

Calcium Dietary Supplement

View page
US Patent:
58796983, Mar 9, 1999
Filed:
Apr 3, 1997
Appl. No.:
8/832079
Inventors:
Leon Ellenbogen - New York NY
Lisa C. Buono - Saddle Brook NJ
Assignee:
American Cyanamid Company - Madison NJ
International Classification:
A61K 968
A61K 920
A61K 914
A61K 3334
US Classification:
424440
Abstract:
A dietary supplement composition is disclosed which comprises a calcium salt, vitamin D and at least one mineral, preferably a boron compound. Other minerals may be present, in addition to, or instead of the boron compound, such as copper compounds, Magnesium compounds, manganese compounds and zinc compounds.

Prenatal Iron Supplements

View page
US Patent:
44316348, Feb 14, 1984
Filed:
Dec 21, 1981
Appl. No.:
6/332413
Inventors:
Leon Ellenbogen - New City NY
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3326
A61K 31295
A61K 3310
A61K 3308
US Classification:
424147
Abstract:
Multimineral dietary supplement compositions of enhanced iron bioavailability are provided by the use of controlled quantities of oxides and carbonates of calcium and magnesium.

3-(4-Biphenylcarbonyl)Propionic Acid As An Inhibitor Of Platelet Aggregation

View page
US Patent:
39669602, Jun 29, 1976
Filed:
Apr 25, 1975
Appl. No.:
5/571826
Inventors:
Leon Ellenbogen - New City NY
Constance Anne Kohler - Nutley NJ
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3119
US Classification:
424317
Abstract:
The use of 3-(4-biphenylcarbonyl)propionic acid in the treatment of blood platelet aggregation.

4-Biphenylacetic Acid As An Inhibitor Of Platelet Aggregation

View page
US Patent:
39669785, Jun 29, 1976
Filed:
Apr 25, 1975
Appl. No.:
5/571815
Inventors:
Leon Ellenbogen - New City NY
Constance Anne Kohler - Nutley NJ
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3119
US Classification:
424317
Abstract:
The use of 4-biphenylacetic acid in the amelioration of blood platelet aggregation.

Isbn (Books And Publications)

Controversies in Nutrition

View page
Author

Leon Ellenbogen

ISBN #

0443081271

Control profile
Leon Roslyn Ellenbogen from Seattle, WA, age ~97 Get Report